Monthly Archives: September 2013

Medtronic wins 2, loses 1

This morning Medtronic (NYSE:MDT) gained FDA approval for their 530G with Enlite® which according to the company is “a first-generation artificial pancreas device system with Threshold Suspend automation for people with diabetes.” While Diabetic Investor believes it’s premature to call this … Continue reading

Posted in Email Alerts | Leave a comment

The FDA Gets It Right

Yesterday the FDA issued final guidance for medical mobile apps and shock of all shocks did not go overboard. For an agency that’s been overly conservative these guidelines are very clear and not overly zealous. That’s the good news however … Continue reading

Posted in Email Alerts | Leave a comment

Another Diabetes Device Dies

Diabetic Investor has learned that Bayer will be closing the production facility for their A1CNow product and cease all production by the end of the year.  For those new to the wacky world of diabetes back in 2006 Bayer acquired … Continue reading

Posted in Email Alerts | Leave a comment

Insulet Medtronic Settle

Diabetic Investor has learned that Insulet (NASDAQ:PODD) and Medtronic (NYSE:MDT) have settled their lawsuit, terms of the settlement were not made public. Investors would be wise to pay very close attention to Insulet’s SEC filings and upcoming quarterly announcements as … Continue reading

Posted in Email Alerts | Leave a comment

The Blackberry Tale

Yesterday former smartphone titan Blackberry warned investors of a huge quarterly operating loss (almost a billion dollars and yes that billion with a B) and also announced they would be axing nearly 4,500 employees. Now some may say this announcement … Continue reading

Posted in Email Alerts | Leave a comment

The drumbeat continues

Diabetic Investor has learned that Abbott (NYSE:ABT) has once again swung the layoff ax eliminating 100 or so positions in their troubled glucose monitoring unit. Speculation within the company is that this is just the first round of cuts and … Continue reading

Posted in Email Alerts | Leave a comment

A “Comical” Moment

It’s been quite some time since we last heard from Paula Deen our friendly racially insensitive celebrity chef who also happens to have diabetes. When last heard from Ms. Deen was dealing with the fallout from her racist remarks made … Continue reading

Posted in Email Alerts | Leave a comment

Just what we needed….

This morning Abbott (NYSE:ABT) Diabetes announced they have received a CE mark for their new FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™. According to a company issued press release; “Abbott (NYSE: ABT) announced today it has received CE … Continue reading

Posted in Email Alerts | Leave a comment

And the hits just keep on coming

Just when it looked like things couldn’t get any worse in the conventional glucose monitoring space, it did. According to an article posted on the QMED website Johnson and Johnson (NYSE:JNJ) could be in a world of hurt in their … Continue reading

Posted in Email Alerts | Leave a comment

A one trick pony

In a stunning turn of events Sanofi (NYSE:SNY) announced this morning they are withdrawing the New Drug Application (NDA) for their once-daily GLP-1 lixisenatide from the FDA. According to a company issued press release; “Sanofi (EURONEXT: SAN and NYSE: SNY) … Continue reading

Posted in Email Alerts | Leave a comment